Todd Waldvogel, left, and Tom Galbreath, listen as Dr. Stuart Flynn, right, explains the type of research he anticipates the new clinical trials consortium will pursue. Galbreath, with Dunaway, served as a moderator for the evening’s panel. (Alexis Allison | Fort Worth)
